Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

What Is Anal Cancer? What Causes Anal Cancer?
Anal cancer occurs in the anus, the end of the gastrointestinal tract. Anal cancer is very different from colorectal cancer, which is much more common. Anal cancer"s causes, risk factors, clinical progression, staging and treatment are all very different from colorectal cancer. Anal cancer is a lump which is created by the abnormal and uncontrolled growth of cells in the anus.
generic viagra online
Milestone Study On Blood Pressure Meds Confirmed By New Research
New research supports the findings of a landmark drug comparison study published in 2002 in which a diuretic drug or "water pill" outperformed other medications for high blood pressure. A scientific team including investigators from The University of Texas Health Science Center at Houston reports the findings in the May 11 issue of the Archives of Internal Medicine. Drugshop to buy zoloft online and other pills.
News of the day
More Camden, N.J., Residents Using Needle Exchange Programs
A pilot needle exchange program in Camden, N.J., - one of four in the state - "was off to a slow start" when it began 18 months ago, but "now, 976 drug users have registered with the program - more people than those at the other pilot sites in Atlantic City, Newark or Paterson," the Cherry Hill Courier-Post reports. "In Camden, 854 people are living with HIV/AIDS, the eighth-highest number among New Jersey municipalities, according to the latest data from the state Department of Health and Senior Services. About a third of them were infected by dirty needles," the Courier-Post reports. Bob Baxter, who oversees Newark"s program, said needle exchanges provide "the most immediate benefit at the cheapest cost," in reducing the spread of blood-borne diseases. "While there"s no way to count the number of people who are no longer sharing needles because of the program, organizers say they hope to see their success correlate to lowered communicable disease rates," the article states (Hirsch, 7/20).
Cardiovascular

European Food Safety Authority Completes First EU-wide Assessment Of Vitamin And Mineral s Used In Food Supplements

The European Food Safety Authority (EFSA) has completed the first comprehensive assessment of substances used as s of vitamins and minerals in food supplements which are currently sold in the European Union. EFSA has examined 533 applications since 2005, relating to 344 different substances. The assessments were based on scientific evidence provided by food supplement manufacturers to demonstrate the safety of these nutrient s and the extent to which they are absorbed in the body (i.e. their bioavailability). 186 applications were withdrawn at various stages during the evaluation process, and EFSA received insufficient scientific evidence to be able to assess around half of the remaining applications. Possible safety concerns were identified in relation to 39 applications. John-Christian Larsen, the Chair of EFSA"s Panel on additives and nutrient s added to food (the ANS Panel), said: "Millions of people across Europe regularly take food supplements in addition to their normal diet. The work of the Panel will help to ensure that the s of vitamins and minerals used in food supplements which are sold in the EU are safe and can effectively provide these nutrients to the body." "Completing this huge task in line with the challenging deadline agreed with the European Commission is an important milestone in EFSA"s work in the area of consumer protection, and represents a significant achievement for the ANS Panel in particular. I would like to thank all of the scientists involved for their hard work." Food supplements are concentrated s of nutrients or other substances with a nutritional or physiological effect, whose purpose is to supplement the normal diet. Examples of the substances assessed by EFSA included chromium nitrate used in food supplements as a of chromium, and vitamin B12-enriched yeast used in supplements as a of vitamin B12. EU Directive 2002/46/EC specifies that only nutrient s whose safety and bioavailability have been assessed by EFSA and listed in the relevant Annex of the Directive can continue to be used in food supplements from 1 January 2010. European Food Safety Authority


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009